177 related articles for article (PubMed ID: 34481663)
21. Selective Serotonin Reuptake Inhibitor Treatment Post Gene Therapy for an Ultrarare Neurometabolic Disorder (AADC Deficiency).
Baribeau DA; Vorstman JAS; Pearson TS
J Am Acad Child Adolesc Psychiatry; 2024 Jun; 63(6):571-573. PubMed ID: 38460745
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of DDC genotypes in patients with aromatic L-amino acid decarboxylase (AADC) deficiency and in silico prediction of structural protein changes.
Himmelreich N; Bertoldi M; Alfadhel M; Alghamdi MA; Anikster Y; Bao X; Bashiri FA; Zeev BB; Bisello G; Ceylan AC; Chien YH; Choy YS; Elsea SH; Flint L; García-Cazorla À; Gijavanekar C; Gümüş EY; Hamad MH; Hişmi B; Honzik T; Hübschmann OK; Hwu WL; Ibáñez-Micó S; Jeltsch K; Juliá-Palacios N; Kasapkara ÇS; Kurian MA; Kusmierska K; Liu N; Ngu LH; Odom JD; Ong WP; Opladen T; Oppeboen M; Pearl PL; Pérez B; Pons R; Rygiel AM; Shien TE; Spaull R; Sykut-Cegielska J; Tabarki B; Tangeraas T; Thöny B; Wassenberg T; Wen Y; Yakob Y; Yin JGC; Zeman J; Blau N
Mol Genet Metab; 2023 Jul; 139(3):107624. PubMed ID: 37348148
[TBL] [Abstract][Full Text] [Related]
23. Aromatic L-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis.
Pons R; Ford B; Chiriboga CA; Clayton PT; Hinton V; Hyland K; Sharma R; De Vivo DC
Neurology; 2004 Apr; 62(7):1058-65. PubMed ID: 15079002
[TBL] [Abstract][Full Text] [Related]
24. A pathogenic S250F missense mutation results in a mouse model of mild aromatic l-amino acid decarboxylase (AADC) deficiency.
Caine C; Shohat M; Kim JK; Nakanishi K; Homma S; Mosharov EV; Monani UR
Hum Mol Genet; 2017 Nov; 26(22):4406-4415. PubMed ID: 28973165
[TBL] [Abstract][Full Text] [Related]
25. Detection of 3-O-methyldopa in dried blood spots for neonatal diagnosis of aromatic L-amino-acid decarboxylase deficiency: The northeastern Italian experience.
Burlina A; Giuliani A; Polo G; Gueraldi D; Gragnaniello V; Cazzorla C; Opladen T; Hoffmann G; Blau N; Burlina AP
Mol Genet Metab; 2021 May; 133(1):56-62. PubMed ID: 33744095
[TBL] [Abstract][Full Text] [Related]
26. New variants of AADC deficiency expand the knowledge of enzymatic phenotypes.
Montioli R; Bisello G; Dindo M; Rossignoli G; Voltattorni CB; Bertoldi M
Arch Biochem Biophys; 2020 Mar; 682():108263. PubMed ID: 31953134
[TBL] [Abstract][Full Text] [Related]
27. 3-O-methyldopa levels in newborns: Result of newborn screening for aromatic l-amino-acid decarboxylase deficiency.
Chien YH; Chen PW; Lee NC; Hsieh WS; Chiu PC; Hwu WL; Tsai FJ; Lin SP; Chu SY; Jong YJ; Chao MC
Mol Genet Metab; 2016 Aug; 118(4):259-63. PubMed ID: 27216367
[TBL] [Abstract][Full Text] [Related]
28. Microstructural changes of brain in patients with aromatic L-amino acid decarboxylase deficiency.
Lee WT; Lin JH; Weng WC; Peng SS
Hum Brain Mapp; 2017 Mar; 38(3):1532-1540. PubMed ID: 27859928
[TBL] [Abstract][Full Text] [Related]
29. The novel P330L pathogenic variant of aromatic amino acid decarboxylase maps on the catalytic flexible loop underlying its crucial role.
Bisello G; Kusmierska K; Verbeek MM; Sykut-Cegielska J; Willemsen MAAP; Wevers RA; Szymańska K; Poznanski J; Drozak J; Wertheim-Tysarowska K; Rygiel AM; Bertoldi M
Cell Mol Life Sci; 2022 May; 79(6):305. PubMed ID: 35593933
[TBL] [Abstract][Full Text] [Related]
30. When dysphoria is not a primary mental state: A case report of the role of the aromatic L-aminoacid decarboxylase.
Portaro S; Gugliandolo A; Scionti D; Cammaroto S; Morabito R; Leonardi S; Fraggetta F; Bramanti P; Mazzon E
Medicine (Baltimore); 2018 Jun; 97(22):e10953. PubMed ID: 29851841
[TBL] [Abstract][Full Text] [Related]
31. Case report: First case report of an Emirati child with a novel gene variant causing aromatic L-amino acid decarboxylase deficiency.
Babiker MOE; Kurian MA; Suleiman J
Front Pediatr; 2022; 10():964201. PubMed ID: 36110109
[TBL] [Abstract][Full Text] [Related]
32. Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up.
Manegold C; Hoffmann GF; Degen I; Ikonomidou H; Knust A; Laass MW; Pritsch M; Wilichowski E; Hörster F
J Inherit Metab Dis; 2009 Jun; 32(3):371-80. PubMed ID: 19172410
[TBL] [Abstract][Full Text] [Related]
33. Compound Heterozygosis in AADC Deficiency and Its Complex Phenotype in Terms of AADC Protein Population.
Bisello G; Bertoldi M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232540
[TBL] [Abstract][Full Text] [Related]
34. Aromatic L-amino acid decarboxylase deficiency in 17 Mainland China patients: Clinical phenotype, molecular spectrum, and therapy overview.
Dai W; Lu D; Gu X; Yu Y;
Mol Genet Genomic Med; 2020 Mar; 8(3):e1143. PubMed ID: 31975548
[TBL] [Abstract][Full Text] [Related]
35. Aromatic L-amino acid decarboxylase deficiency: an extrapyramidal movement disorder with oculogyric crises.
Korenke GC; Christen HJ; Hyland K; Hunneman DH; Hanefeld F
Eur J Paediatr Neurol; 1997; 1(2-3):67-71. PubMed ID: 10728198
[TBL] [Abstract][Full Text] [Related]
36. Human aromatic amino acid decarboxylase is an asymmetric and flexible enzyme: Implication in aromatic amino acid decarboxylase deficiency.
Bisello G; Ribeiro RP; Perduca M; Belviso BD; Polverino De' Laureto P; Giorgetti A; Caliandro R; Bertoldi M
Protein Sci; 2023 Aug; 32(8):e4732. PubMed ID: 37466248
[TBL] [Abstract][Full Text] [Related]
37. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons.
Pearson TS; Gupta N; San Sebastian W; Imamura-Ching J; Viehoever A; Grijalvo-Perez A; Fay AJ; Seth N; Lundy SM; Seo Y; Pampaloni M; Hyland K; Smith E; de Oliveira Barbosa G; Heathcock JC; Minnema A; Lonser R; Elder JB; Leonard J; Larson P; Bankiewicz KS
Nat Commun; 2021 Jul; 12(1):4251. PubMed ID: 34253733
[TBL] [Abstract][Full Text] [Related]
38. Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency.
Montioli R; Cellini B; Borri Voltattorni C
J Inherit Metab Dis; 2011 Dec; 34(6):1213-24. PubMed ID: 21541720
[TBL] [Abstract][Full Text] [Related]
39. Aromatic L-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different therapies.
Fiumara A; Bräutigam C; Hyland K; Sharma R; Lagae L; Stoltenborg B; Hoffmann GF; Jaeken J; Wevers RA
Neuropediatrics; 2002 Aug; 33(4):203-8. PubMed ID: 12368991
[TBL] [Abstract][Full Text] [Related]
40. Recurrent Dystonic Crisis and Rhabdomyolysis Treated with Dantrolene in Two Patients with Aromatic L-Amino Acid Decarboxylase Deficiency.
Micallef J; Stockler-Ipsiroglu S; van Karnebeek CD; Salvarinova-Zivkovic R; Horvath G
Neuropediatrics; 2020 Jun; 51(3):229-232. PubMed ID: 31935764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
